🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-20
Trial ID
NCT01665144
to quantify the effect of different degrees of renal impairment on the phar...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-07
Trial ID
NCT01904214
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and effect...
Status
Completed
Location
Novartis
Start Date
2006-10
Trial ID
NCT00422175
Treatments Being Tested
To assess safety and tolerability of patients converting from approved Rela...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-14
Trial ID
NCT03623243
Treatments Being Tested
Collaboration with multiple sclerosis (MS) specialty colleagues led us to f...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2025-08-26
Trial ID
NCT06639282
This study determined the efficacy, safety, tolerability and the PK profile...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-06-15
Trial ID
NCT01148810
This study investigated the dose response relationship for the efficacy and...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-08-25
Trial ID
NCT02029274
The purpose of this study was to determine the dose-response curve for the ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03-30
Trial ID
NCT00879658
This study will investigate the pharmacokinetics of BAF312 in patients with...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01565902
Treatments Being Tested